FairVision: Equitable Deep Learning for Eye Disease Screening via Fair Identity Scaling
Yan Luo, Muhammad Osama Khan, Yu Tian, Min Shi, Zehao Dou, Tobias, Elze, Yi Fang, Mengyu Wang

TL;DR
This paper investigates fairness issues in 3D eye disease screening models, revealing biases across demographic groups, and introduces a novel method and dataset to improve equity in medical AI.
Contribution
It is the first comprehensive study on 3D medical imaging fairness, proposing a new fair identity scaling method and releasing a large-scale dataset for equitable AI research.
Findings
Significant biases found across race, gender, and ethnicity in 3D models
The proposed FIS method outperforms existing fairness techniques
Harvard-FairVision dataset enables large-scale fairness analysis
Abstract
Equity in AI for healthcare is crucial due to its direct impact on human well-being. Despite advancements in 2D medical imaging fairness, the fairness of 3D models remains underexplored, hindered by the small sizes of 3D fairness datasets. Since 3D imaging surpasses 2D imaging in SOTA clinical care, it is critical to understand the fairness of these 3D models. To address this research gap, we conduct the first comprehensive study on the fairness of 3D medical imaging models across multiple protected attributes. Our investigation spans both 2D and 3D models and evaluates fairness across five architectures on three common eye diseases, revealing significant biases across race, gender, and ethnicity. To alleviate these biases, we propose a novel fair identity scaling (FIS) method that improves both overall performance and fairness, outperforming various SOTA fairness methods. Moreover, we…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal Imaging and Analysis · Retinal Diseases and Treatments · Acute Ischemic Stroke Management
